Bristol Myers Squibb CEO Christopher Boerner goes one-on-one with Jim Cramer

Bristol Myers Squibb CEO Christopher Boerner joins ‘Mad Money’ host Jim Cramer to talk its new schizophrenia treatment Cobenfy, its oncology business, and more.